Triglyceride News and Research

RSS

Triglycerides are a type of fat in the bloodstream and fat tissue. Too much of this type of fat can contribute to the hardening and narrowing of your arteries. This puts you at risk of having a heart attack or stroke. Diseases such as diabetes, obesity, kidney failure or alcoholism can cause high triglycerides. Often, high triglycerides occur along with high levels of cholesterol, another type of fat. Triglycerides are measured along with cholesterol as part of a blood test. Normal triglyceride levels are below 150. Levels above 200 are high.

Beverage fructose intake may lead to an abnormal cardiometabolic profile

A new study describes that fructose intake from sugar-sweetened beverages can cause cardiometabolic disorders. In contrast, fruit fructose was found to be good for cardiometabolic health.

16 Jan 2023

How do fruit, whole grains, and trout-based dietary interventions impact obesity management?

Scientists have described the effectiveness of a specific diet containing fruit, avocado, whole grains, and trout in controlling inflammation and oxidative stress in obese individuals.

10 Jan 2023

New insights into the bioavailability and hepatoxicity risk of neonicotinoids

Researchers quantified the residues of eight neonicotinoids in human bile samples to understand the association between internal neonicotinoid exposure and hepatotoxic outcomes.

4 Jan 2023

Dietary supplement can reverse the signs of heart disease in a subset of patients

When we were little, our parents told us to take our vitamins so we could grow big and strong. Now, researchers from Japan find that one particular supplement may even fix a broken heart.

4 Jan 2023

The metabolic links between diet-induced changes in the gut and NASH

Scientists reviewed the metabolic association between diet-induced alterations in the gut and NASH

4 Jan 2023

Olive oil is beneficial for maternal-fetal health

There have been numerous studies showing how olive oil affects pregnancy. In a recent study published in the journal Nutrition Research, evidence was gathered for its effects on fetomaternal outcomes. The results are interesting, suggesting a protective effect on these outcomes.

3 Jan 2023

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Very low-calorie diets and vegan diets improve weight loss and anthropometric markers in type 2 diabetes patients.

1 Dec 2022

Moderate alcohol intake may affect lipoprotein metabolism

A recent Nutrients journal study evaluated the impact of 1-2 drinks of alcohol per day on cardiovascular biomarkers in the cross-over intervention, prospective, and assessor-blinded trial called the Metabolic Imprints of Alcoholic Beverages (MetAl).

30 Nov 2022

Honey improves key measures of health, including blood sugar and cholesterol levels

Researchers look to better understand the impact of honey on mitigating certain cardiometabolic risk factors.

20 Nov 2022

Lipid screening and dyslipidemia intervention in adolescence may stop atherosclerosis progression

Consistently elevated lipids and dyslipidemia in early life were associated with worsening subclinical atherosclerosis, but simulated lipid treatment in late adolescence stopped atherosclerosis progression, a paper published in Atherosclerosis concludes.

15 Nov 2022

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

A new medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes yet did not decrease their cardiovascular risk, according to late-breaking science research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Rosuvastatin vastly superior to six common heart health supplements

Six widely used dietary supplements often advertised to promote heart health are actually ineffective at lowering cholesterol levels.

7 Nov 2022

Novel drug lowers triglycerides, does not reduce cardiovascular events

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice.

6 Nov 2022

Circadian disruption induces weight gain through changes in gut microbiota

In a recent study published in the journal Molecular Metabolism, researchers investigated the impact of environmental and genetic disruptions of the circadian rhythms on the peripheral circadian clock synchronization and microbiome oscillations in the gastrointestinal tract.

3 Nov 2022

Single-nucleus RNA sequencing and spatial transcriptome atlas of COVID-19 livers

Researchers performed single-nucleus RNA sequencing (snRNA-seq) and spatial transcriptomic profiling of livers from deceased coronavirus disease 2019 (COVID-19) patients.

1 Nov 2022

In utero exposure to flame retardant results in altered brain development in newborn rats

A new study from North Carolina State University shows that exposure in utero to the flame retardant FireMaster 550 (FM 550), or to its individual brominated (BFR) or organophosphate ester (OPFR) components, resulted in altered brain development in newborn rats.

24 Oct 2022

Walnut consumption early on in life may lead to better health as we age

Researchers who reviewed 20 years of diet history and 30 years of physical and clinical measurements have found participants who ate walnuts early on in life showed a greater likelihood for being more physically active, having a higher quality diet, and experiencing a better heart disease risk profile as they aged into middle adulthood.

14 Sep 2022

Semaglutide appears to be an effective medication for treating obesity, study says

The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden (19-23 Sept).

12 Sep 2022

UT Southwestern scientists identify genetic mutations that contribute to nonalcoholic fatty liver disease

Using a genetic screening platform developed by a UT Southwestern Nobel Laureate, scientists with the Center for the Genetics of Host Defense at UT Southwestern Medical Center have identified genetic mutations that contribute to nonalcoholic fatty liver disease (NAFLD), providing a potential future target for therapeutic interventions.

9 Sep 2022

Study finds link between high-density lipoprotein and COVID-19

A new study has highlighted the significance of high-density lipoprotein COVID-19 pathogenesis and outcome.

24 Aug 2022

Triglyceride News and Research

Further Reading

Beverage fructose intake may lead to an abnormal cardiometabolic profile

How do fruit, whole grains, and trout-based dietary interventions impact obesity management?

New insights into the bioavailability and hepatoxicity risk of neonicotinoids

Dietary supplement can reverse the signs of heart disease in a subset of patients

The metabolic links between diet-induced changes in the gut and NASH

Olive oil is beneficial for maternal-fetal health

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Moderate alcohol intake may affect lipoprotein metabolism

Honey improves key measures of health, including blood sugar and cholesterol levels

Lipid screening and dyslipidemia intervention in adolescence may stop atherosclerosis progression

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

Rosuvastatin vastly superior to six common heart health supplements

Novel drug lowers triglycerides, does not reduce cardiovascular events

Circadian disruption induces weight gain through changes in gut microbiota

Single-nucleus RNA sequencing and spatial transcriptome atlas of COVID-19 livers

In utero exposure to flame retardant results in altered brain development in newborn rats

Walnut consumption early on in life may lead to better health as we age

Semaglutide appears to be an effective medication for treating obesity, study says

UT Southwestern scientists identify genetic mutations that contribute to nonalcoholic fatty liver disease

Study finds link between high-density lipoprotein and COVID-19

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News